Mirjam Boelens to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Mirjam Boelens has written about Drug Resistance, Neoplasm.
Connection Strength
0.380
-
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study. Neuro Oncol. 2024 Dec 05; 26(12):2316-2327.
Score: 0.169
-
Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib +/- binimetinib or alpelisib. Br J Cancer. 2021 01; 124(1):176-182.
Score: 0.128
-
Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell. 2014 Oct 23; 159(3):499-513.
Score: 0.084